Sugi Predict

Sugi Predict / Compounds / SCHEMBL280594

SCHEMBL280594

SCHEMBL280594

NC(=O)c1nsc2ccc(Br)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLG P00747 1/20 0.39
▸ PLAU P00749 1/20 0.39
▸ PLAT P00750 1/20 0.39
▸ DGAT1 O75907 1/20 0.39
▸ RXFP1 Q9HBX9 2/20 0.38
▸ DYRK1A Q13627 3/20 0.37
▸ PARP1 P09874 1/20 0.37
▸ PIM1 P11309 2/20 0.37
▸ PRKACA P17612 2/20 0.37
▸ CSNK1A1 P48729 2/20 0.37
▸ CLK2 P49760 2/20 0.37
▸ GSK3A P49840 2/20 0.37
▸ GSK3B P49841 2/20 0.37
▸ RPS6KA3 P51812 2/20 0.37
▸ CDK5 Q00535 2/20 0.37
▸ MAP4K2 Q12851 2/20 0.37
▸ ROCK1 Q13464 2/20 0.37
▸ CLK4 Q9HAZ1 2/20 0.37
▸ DAPK3 O43293 1/20 0.37
▸ PRKD3 O94806 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4777702 0.87 DGAT1 (0.39) PLGPLAUPLATDGAT1RXFP1
SCHEMBL30211551 0.85 RXFP1 (0.41) RXFP1DYRK1ACYP2A6KMT2AMEN1
SCHEMBL260474 0.85 RXFP1 (0.41) RXFP1DYRK1ACYP2A6KMT2AMEN1
SCHEMBL23088340 0.80 ALDH1A1 (0.40) PARP1CYP2A6
SCHEMBL23984468 0.80 MAP2K4 (0.41) DYRK1APARP1CDK8ICAM1SELE
SCHEMBL31028460 0.80 DYRK1A (0.38) DYRK1APARP1PIM1PRKACACSNK1A1
SCHEMBL15898941 0.80 ELANE (0.46) DYRK1ANPC1CYP1A2CYP3A4CYP2C9
SCHEMBL1635139 0.76 ELANE (0.49) RXFP1KMT2AMEN1NPC1CYP1A2
SCHEMBL1572476 0.75 MAPT (0.52) RXFP1LIMK1
SCHEMBL9958324 0.74 DGAT1 (0.33) DGAT1DYRK1APIM1PRKACAGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017128896-A1 FXR AGONIST AND PREPARATION METHOD AND USE THEREOF 江苏豪森药业集团有限公司 2017-08-03 — — WO disclosed
US-8134003-B2 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2012-03-13 — — US disclosed
US-20110212957-A1 INDAZOLES, BENZOTHIAZOLES, AND BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF XIE WENGE 2011-09-01 — — US disclosed
US-7943773-B2 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof MEMORY PHARMACEUTICALS CORPORATION (US) 2011-05-17 — — US disclosed
US-20090209579-A1 INDAZOLES, BENZOTHIAZOLES, AND BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF XIE WENGE 2009-08-20 — — US disclosed
US-20080176890-A1 INDAZOLES, BENZOTHIAZOLES, AND BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF XIE WENGE 2008-07-24 — — US disclosed
US-20080154037-A1 INDAZOLES, BENZOTHIAZOLES, AND BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF XIE WENGE 2008-06-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209579-A1 INDAZOLES, BENZOTHIAZOLES, AND BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF CHRNA7, CHRNA5, CHRNA3 PLG 4149/4885PLAU 4330/4885PLAT 3751/4885
US-20080154037-A1 INDAZOLES, BENZOTHIAZOLES, AND BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF CHRNA7, CHRNA5, CHRNA3 PLG 4149/4885PLAU 4330/4885PLAT 3751/4885
US-20110212957-A1 INDAZOLES, BENZOTHIAZOLES, AND BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF CHRNA7, CHRNA5, CHRNA3 PLG 4149/4885PLAU 4330/4885PLAT 3751/4885
US-20080176890-A1 INDAZOLES, BENZOTHIAZOLES, AND BENZOISOTHIAZOLES, AND PREPARATION AND USES THEREOF CHRNA7, CHRNA5, CHRNA3 PLG 4149/4885PLAU 4330/4885PLAT 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.